Applied BioCode Obtains Emergency Use Authorization for CoV-2 Flu Plus Assay

SANTA FE SPRINGS, Calif.–(BUSINESS WIRE)–We have taken an important next step in strengthening our infectious disease menu by upgrading the BioCode® SARS-CoV-2 Test.